rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Lakeland Industries, Inc.

LAKE · Nasdaq

Health CareMedical DevicesNot moving yet

LAKE stood above a rising 150-day average in 7 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 12.8% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 3
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$114K
Insider sales, 12 months
$71K
Officials’ trades on record
0
Institutions holding
67 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$58K$0$284KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months7
Sale orders, 12 months1
Buyers · sellers6 · 1
WhoDidSharesTraded
Cameron StokesOfficerbought450at $9.4313 Jan 2026filed 15 Jan 2026
An HuiChief Operating Officerbought2,000at $8.979 Jan 2026filed 12 Jan 2026
James Calven Swinea, Jr.Interim CFObought1,000at $8.719 Jan 2026filed 9 Jan 2026
James M. JenkinsPresident, CEO & Exec. Chairbought1,126.502at $8.885 Jan 2026filed 5 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders67+0 on the quarter
New · exited20 · 21
Reported value$69.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
ROYCE & ASSOCIATES LPadded · filed 14 Aug 20261,319,086$14.1M+105,664+8.7%
Private Capital Management, LLCreduced · filed 14 Aug 20261,249,274$13.4M-258,949−17.2%
Pacific Ridge Capital Partners, LLCadded · filed 12 Aug 2026975,881$10.4M+46,900+5.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026393,129$4.2M+1,829+0.5%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026320,235$3.4M-8,909−2.7%
MORGAN STANLEYreduced · filed 13 Aug 2026268,285$2.9M-615−0.2%
MARSHALL WACE, LLPnew · filed 13 Aug 2026234,575$2.5M+234,575
Peapod Lane Capital LLCadded · filed 27 Jul 2026207,657$2.2M+79,539+62.1%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026182,802$2.0M-17,600−8.8%
BlackRock, Inc.reduced · filed 7 Aug 2026158,276$1.7M-398,161−71.6%
31 Mar 2023 – 30 Jun 2026
415977Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Laurel A. Yartz Company insiderChief Human Resources Officer · last 1 Aug 20263 · 0
Melissa Kidd Company insiderDirector · last 1 Aug 20261 · 0
Ronald N. Herring Jr. Company insiderDirector · last 1 Aug 20260 · 0
An Hui Company insiderChief Operating Officer · last 11 Jul 20263 · 0
Barry G. Phillips Company insiderChief Revenue Officer - Fire · last 11 Jul 20261 · 0
James M. Jenkins Company insiderPresident, CEO & Exec. Chair · last 11 Jul 20267 · 0
Jeffrey T. Schlarbaum Company insiderDirector · last 16 Jun 20260 · 0
Lee D. Rudow Company insiderDirector · last 16 Jun 20260 · 0
Martin G. Glavin Company insiderDirector · last 16 Jun 20261 · 0
Nikki Hamblin Company insiderDirector · last 16 Jun 20262 · 0
Thomas J. McAteer Company insiderDirector · last 16 Jun 20260 · 6
Cameron Stokes Company insiderOfficer · last 27 May 20261 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2026 · to 31 Jan 202632.9%
Operating profit marginFY 2026 · to 31 Jan 2026-8.1%
Free cash flow marginFY 2026 · to 31 Jan 2026-8.5%
Return on capital employedFY 2026 · to 31 Jan 2026-9.0%
Debt to equityFY 2026 · to 31 Jan 20260.25×
Interest coverFY 2026 · to 31 Jan 2026-7.22×
Share count trendFY 2026 · to 10 Apr 20269.4%
Cash and equivalentsFY 2026 · to 31 Jan 2026$12.5M
Free cash flowFY 2026 · to 31 Jan 2026−$16.4M

Analyst forecasts

No analyst forecasts yet.